Macrophage cell membranecloaked nanoplatforms for biomedical applications

J Lopes, D Lopes, M PereiraSilva, D Peixoto… - Small …, 2022 - Wiley Online Library
Biomimetic approaches utilize natural cell membranederived nanovesicles to camouflage
nanoparticles to circumvent some limitations of nanoscale materials. This emergent cell …

Biologically modified nanoparticles as theranostic bionanomaterials

J Yang, X Zhang, C Liu, Z Wang, L Deng… - Progress in Materials …, 2021 - Elsevier
Inspired by natural biology, cell membrane-mimetic surface engineering and cell membrane
camouflaging technology have been widely investigated. Notably, the cell membrane …

Bioengineered exosomal-membrane-camouflaged abiotic nanocarriers: neurodegenerative diseases, tissue engineering and regenerative medicine

D Lopes, J Lopes, M Pereira-Silva, D Peixoto… - Military Medical …, 2023 - Springer
A bio-inspired strategy has recently been developed for camouflaging nanocarriers with
biomembranes, such as natural cell membranes or subcellular structure-derived …

Design of experiments in the optimization of nanoparticle-based drug delivery systems

R Rampado, D Peer - Journal of Controlled Release, 2023 - Elsevier
Abstract Design of experiment (DoE) is a powerful statistical technique used for variable
screening and optimization. It is based on the simultaneous variation of multiple factors with …

Cell membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell internalization and anticancer efficacy

Z Hussain, MA Rahim, N Jan, H Shah… - Journal of Controlled …, 2021 - Elsevier
Despite enormous advancements in the field of oncology, the innocuous and effectual
treatment of various types of malignancies remained a colossal challenge. The conventional …

Advances in lipid-based carriers for cancer therapeutics: Liposomes, exosomes and hybrid exosomes

DN Moholkar, R Kandimalla, RC Gupta, F Aqil - Cancer Letters, 2023 - Elsevier
Cancer has recently surpassed heart disease as the leading cause of deaths worldwide for
the age group 45–65 and has been the primary focus for biomedical researchers. Presently …

Artificial exosomes for translational nanomedicine

YJ Li, JY Wu, J Liu, W Xu, X Qiu, S Huang… - Journal of …, 2021 - Springer
Exosomes are lipid bilayer membrane vesicles and are emerging as competent
nanocarriers for drug delivery. The clinical translation of exosomes faces many challenges …

Biomimetic AntiPD1 PeptideLoaded 2D FePSe3 Nanosheets for Efficient Photothermal and Enhanced Immune Therapy with Multimodal MR/PA/Thermal Imaging

X Fang, X Wu, Z Li, L Jiang, WS Lo, G Chen… - Advanced …, 2021 - Wiley Online Library
Metal phosphorous trichalcogenides (MPX3) are novel 2D nanomaterials that have recently
been exploited as efficient photothermal–chemodynamic agents for cancer therapy. As a …

Hybrid extracellular vesicles for drug delivery

C Ducrot, S Loiseau, C Wong, E Madec, J Volatron… - Cancer Letters, 2023 - Elsevier
Extracellular vesicles (EVs) are expected to serve as interesting drug delivery vectors as
they may offer unique and new properties for drug delivery. Their natural origin, protein and …

Cell membrane-based biomimetic nanoparticles and the immune system: immunomodulatory interactions to therapeutic applications

M Sushnitha, M Evangelopoulos, E Tasciotti… - … in bioengineering and …, 2020 - frontiersin.org
Nanoparticle-based drug delivery systems have been synthesized from a wide array of
materials. The therapeutic success of these platforms hinges upon their ability to favorably …